Analysts Issue Forecasts for CATX Q4 Earnings
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Equities researchers at HC Wainwright issued their Q4 2024 earnings per share estimates for shares of Perspective Therapeutics in a research note issued to investors on Thursday, March 13th. HC Wainwright analyst R. Burns anticipates that the company will post earnings per share of ($0.24) for the […]
